SEC Comment Letter 0000000000-25-003272 to Senti Biosciences, Inc. (SNTI) (CIK 0001854270) (SNTI)
Senti Biosciences, Inc. (SNTI) (CIK 0001854270)
Date: March 26, 2025 · CIK: 0001854270 · Accession: 0000000000-25-003272
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285985
Letter
Re: Senti Biosciences, Inc. Registration Statement on Form S-3 Filed March 21, 2025 File No. 333-285985 Dear Timothy Lu:
March 26, 2025
Timothy Lu Chief Executive Officer Senti Biosciences, Inc. 2 Corporate Drive, First Floor South San Francisco, CA 94080
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Swetha Gopalakrishnan, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 26, 2025 Timothy Lu Chief Executive Officer Senti Biosciences, Inc. 2 Corporate Drive, First Floor South San Francisco, CA 94080 Re: Senti Biosciences, Inc. Registration Statement on Form S-3 Filed March 21, 2025 File No. 333-285985 Dear Timothy Lu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Swetha Gopalakrishnan, Esq. </TEXT> </DOCUMENT>